title: Changes in atherosclerosis markers during tocilizumab treatment in rheumatoid arthritis: preliminary results.
authors: Maurizio
authors: M
authors: Benucci
authors: Mariangela
authors: M
authors: Manfredi
authors: Gianantonio
authors: G
authors: Saviola
authors: Piercarlo
authors: P
authors: Sarzi-Puttini
authors: Fabiola
authors: F
authors: Atzeni
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D050197:Atherosclerosis / Q000097:blood / Q000276:immunology*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D008875:Middle Aged; D011446:Prospective Studies; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D015415:Biomarkers; D018836:Inflammation Mediators; C502936:tocilizumab